
Sign up to save your podcasts
Or


Netflix rises on strong 1st quarter numbers and a well-executed price increase. Valeant Pharmaceuticals makes a $45 billion bid for Allergan. Plus, we analyze the latest results from McDonald’s and the new “Pay To Quit” program at Amazon.
By The Motley Fool4.7
16041,604 ratings
Netflix rises on strong 1st quarter numbers and a well-executed price increase. Valeant Pharmaceuticals makes a $45 billion bid for Allergan. Plus, we analyze the latest results from McDonald’s and the new “Pay To Quit” program at Amazon.

3,221 Listeners

1,487 Listeners

808 Listeners

948 Listeners

520 Listeners

1,168 Listeners

2,184 Listeners

825 Listeners

1,423 Listeners

1,039 Listeners

9,717 Listeners

195 Listeners

826 Listeners

85 Listeners

585 Listeners

1,039 Listeners

54 Listeners